Company News, Financial News

Galderma Delivers Strong FY 2022 Growth

Year-on-year net sales growth for dermatological skincare was 22.3%.

Author Image

By: Lianna Albrizio

Associate Editor

Galderma delivered at the top end of its 2022 revenue guidance with 13.9% year-on-year net sales growth on a constant currency basis at $3.7 billion, the company reported.    It also delivered above its 2022 profitability guidance with 14.5% Core Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) year-on-year growth on a constant currency basis at $791 million.   The company sustained growth momentum fueled by continued strong performance in Injectable Aesth...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters